Schedule 13D ownership disclosure

Immunovant Inc

Security class unavailable · CUSIP: 45258J102

Event date: 2019-12-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
37,414,967
Percent of class
66.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-075127
Form type
SC 13D
Filer
Immunovant, Inc.
CIK
CIK 1764013
Filed
Dec 20, 2019
Reporting period
Dec 18, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub